Sign In
Buy SOLV
$74.56
-2.00 (-2.61%)
At Close: Jun 17, 2026
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.
08:00am, Tuesday, 02'nd Sep 2025
Accelerates Solventum's business transformation to deliver long-term shareholder value Net proceeds will be used primarily to pay down debt ST. PAUL, Minn.
Solventum to Participate in Upcoming Investor Conferences
04:05pm, Thursday, 28'th Aug 2025
ST. PAUL, Minn. , Aug. 28, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences: 2025 Wells Fargo Healt
Solventum Announces $1.75 Billion Note Tender Offers
08:19am, Friday, 22'nd Aug 2025
ST. PAUL, Minn. , Aug. 22, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV) announced today that it has commenced offers (each, a "Tender Offer" and, collectively, the "Tender Offers") to purch
Solventum Announces Pricing of Secondary Offering of Common Stock
10:39pm, Wednesday, 13'th Aug 2025
ST. PAUL, Minn. , Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV) (the "Company" or "Solventum") today announced the pricing of the previously announced secondary offering (the "Offe
Solventum Announces Launch of Secondary Offering of Common Stock
04:48pm, Wednesday, 13'th Aug 2025
ST. PAUL, Minn. , Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV, "Company" or "Solventum") today announced the launch of a secondary offering (the "Offering") of 8,800,000 shares of
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve
10:46am, Friday, 08'th Aug 2025
SOLV jumps 5% as Q2 earnings and revenues beat estimates; EPS outlook raised on broad-based segment growth.
Solventum Corporation (SOLV) Q2 2025 Earnings Call Transcript
06:53am, Friday, 08'th Aug 2025
Solventum Corporation (NYSE:SOLV ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communic
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Thursday, 07'th Aug 2025
Although the revenue and EPS for Solventum (SOLV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates
06:26pm, Thursday, 07'th Aug 2025
Solventum (SOLV) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.56 per share a year ago.
Solventum (SOLV) Fiscal Q2 EPS Jumps 8%
06:21pm, Thursday, 07'th Aug 2025
Solventum (SOLV) Fiscal Q2 EPS Jumps 8%
Solventum raises annual profit forecast on strength in surgical equipment
04:52pm, Thursday, 07'th Aug 2025
Medical device maker Solventum raised full-year adjusted profit forecast on Thursday, driven by strong sales of its wound care and surgical sterilization products alongside lower expenses.
Solventum Reports Second Quarter 2025 Financial Results
04:05pm, Thursday, 07'th Aug 2025
Reported sales increased 3.9%; organic sales increased 2.8% Increases full year organic sales growth outlook to +2.0% to +3.0% Increases full year earnings per share outlook to $5.80 to $5.95 ST. PAUL
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
12:46pm, Tuesday, 05'th Aug 2025
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
Ahead of Solventum (SOLV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:15am, Tuesday, 05'th Aug 2025
Beyond analysts' top-and-bottom-line estimates for Solventum (SOLV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarte
Solventum: Appealing Again
09:12am, Tuesday, 22'nd Jul 2025
Solventum's $4.1B sale of its purification business to Thermo Fisher significantly reduces debt and enhances financial stability, improving long-term prospects. Despite near-term earnings pressure fro
